Radiotherapy and Oncology

Title Publication Date Language Citations
Comments on “Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study”2024/04/01English
Aims+Scope/Editorial Board/ Publication information2024/05/01English
Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer2024/04/01English
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer2024/04/01English
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)English
Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV marginEnglish
164 Relation between cumulative doses and early complications in patients with transperineal Ir 192 wire implants1996/05/01English
Radiation induced G1-block and p53 status in six human cell lines1995/10/01English
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy – An evaluation of dosimetric performances2024/05/01English
Response to letter to the editor regarding “External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts” by M. Berbée et al.2024/04/01English
Monte Carlo based 3D treatment planning systems for BNCT at Petten1995/10/01English
Acute reaction parameters for human oropharyngeal mucosa1995/05/01English
Improving the accuracy of fast 3D photon dose calculations with the aid of a superposition algorithm1995/10/01English
Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 1448721995/01/01English
RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa)1997/03/01English
Prediction of normal-tissue tolerance from in vitro cellular radiation sensitivity1995/09/01English
72 High dose rate brachytherapy for the treatment of soft tissue sarcoma of the extremity1996/05/01English
Prediction of field size and SSD dependence of wedge factors1995/10/01English
Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck1995/01/01English
61 Some aspects of the relation between the volume of prostate carcinoma and its interstitial bt volume1996/05/01English
Status of quality assurance of treatment planning systems in Europe1995/10/01English
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects1995/05/01English
A Code of Practice for Clinical Proton dosimetry1995/10/01English
Field size dependence of wedge factor: Miniphantom vs full phantom measurements1995/10/01English
Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer1997/09/01English
Effect of intra-peritoneal fludarabine on rat spinal cord tolerance to fractionated irradiation1995/07/01English
Quality assurance for a 192Ir wire source dosimetry1995/10/01English
Radiation yield and maximum beta range of spilled radionuclide Sr-891995/10/01English
69 Role of brachytherapy with or without external beam radiation in the management of desmoid tumors1996/05/01English
The European core curriculum for radiotherapy technologists1997/04/01English